Quick Answer
BIOCRYST PHARMACEUTICALS INC reported Earnings Per Share Diluted of $1.21 per share for the year ending 2025.
- BIOCRYST PHARMACEUTICALS INC showed an increase of +381.4% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from BIOCRYST PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), BIOCRYST PHARMACEUTICALS INC's Earnings Per Share Diluted has grown by 211.0%.
- Historical annual values: Fiscal year 2025: $1.21 per share | Fiscal year 2024: $0.43 (loss) per share | Fiscal year 2023: $1.18 (loss) per share | Fiscal year 2022: $1.33 (loss) per share | Fiscal year 2021: $1.03 (loss) per share | Fiscal year 2020: $1.09 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: